Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial.
Saved in:
| Title: | Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial. |
|---|---|
| Authors: | Shah NN; Pediatric Oncology Branch, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Schafer ES; Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Cancer and Hematology Center, Houston, Texas, USA., Chi YY; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Malvar J; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA., Heym KM; Hematology and Oncology, Cook Children's Medical Center, Fort Worth, Texas, USA., Place AE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Burns M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Chang BH; Division of Hematology and Oncology, Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA., Slone T; Children's Medical Center, UT Southwestern, Dallas, Texas, USA., Verma A; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.; Division of Pediatric Hematology Oncology, Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA., Gossai N; Center for Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota, USA., Shaw PH; Division of Hematology and Oncology, Department of Pediatrics, Children's Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Burke MJ; Division of Hematology and Oncology, Department of Pediatrics, Children's Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Hermiston M; Pediatric Hematology/Oncology, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA., Schore RJ; Division of Pediatric Oncology, Children's National Hospital/George Washington University SMHS, Washington, District of Columbia, USA., Cooper T; Seattle Children's Cancer and Blood Disorders Center, University of Washington, Seattle, Washington, USA., Pauly M; Department of Pediatric Hematology Oncology, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Rushing T; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; Department of Pharmacy, Children's Hospital Los Angeles, Los Angeles, California, USA., Jarosinski P; Pediatric Oncology Branch, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Florendo E; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA., Yates B; Pediatric Oncology Branch, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Widemann BC; Pediatric Oncology Branch, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Peer CJ; Clinical Pharmacology Laboratory, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Figg WD; Clinical Pharmacology Laboratory, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Silverman LB; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Medical Center, New York, New York, USA., Bhojwani D; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Wayne AS; Division of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2025 May; Vol. 72 (5), pp. e31584. Date of Electronic Publication: 2025 Feb 12. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-5017 |
|---|---|
| DOI: | 10.1002/pbc.31584 |
